Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Cellular Signalling
|
August 25, 2012
The extracellular-regulated protein kinase 5 (ERK5) promotes cell proliferation through the down-regulation of inhibitors of cyclin dependent protein kinases (CDKs)
Diana Perez-Madrigal, Katherine G Finegan, Blanca Paramo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 25, 2011
The loss of c-Jun N-terminal protein kinase activity prevents the amyloidogenic cleavage of amyloid precursor protein and the formation of amyloid plaques in vivo
Sonia Mazzitelli, Ping Xu, Isidre Ferrer, et al.
Cell Reports
|
March 8, 2016
Fibroblast Growth Factor 21 Mediates Glycemic Regulation by Hepatic JNK
Santiago Vernia, Julie Cavanagh-Kyros, Tamera Barrett, et al.
Journal of Leukocyte Biology
|
August 26, 2015
Dual role of ERK5 in the regulation of T cell receptor expression at the T cell surface
Xavier Rovira-Clavé, Maria Angulo-Ibáñez, Cathy Tournier, et al.
Molecular and Cellular Neurosciences
|
March 2, 2005
Activation of integrin alpha5beta1 delays apoptosis of Ntera2 neuronal cells
Rosemary M Gibson, Susan E Craig, Laura Heenan, et al.
Biomedicines
|
November 11, 2022
Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways
Serena Filiberti, Mariapia Russo, Silvia Lonardi, et al.
Cellular Signalling
|
July 30, 2010
Alternative ERK5 regulation by phosphorylation during the cell cycle
Francisco A Iñesta-Vaquera, David G Campbell, Cathy Tournier, et al.
FEBS Letters
|
February 7, 2006
The regulation of Bax by c-Jun N-terminal protein kinase (JNK) is a prerequisite to the mitochondrial-induced apoptotic pathway
Emmanouil S Papadakis, Katherine G Finegan, Xin Wang, et al.
European Journal of Immunology
|
September 16, 2008
ERK5 regulation in naïve T-cell activation and survival
Olga Ananieva, Andrew Macdonald, Xin Wang, et al.
Cancer Research
|
February 5, 2015
ERK5 is a critical mediator of inflammation-driven cancer
Katherine G Finegan, Diana Perez-Madrigal, James R Hitchin, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Cellular Signalling
|
August 25, 2012
The extracellular-regulated protein kinase 5 (ERK5) promotes cell proliferation through the down-regulation of inhibitors of cyclin dependent protein kinases (CDKs)
Diana Perez-Madrigal, Katherine G Finegan, Blanca Paramo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 25, 2011
The loss of c-Jun N-terminal protein kinase activity prevents the amyloidogenic cleavage of amyloid precursor protein and the formation of amyloid plaques in vivo
Sonia Mazzitelli, Ping Xu, Isidre Ferrer, et al.
Cell Reports
|
March 8, 2016
Fibroblast Growth Factor 21 Mediates Glycemic Regulation by Hepatic JNK
Santiago Vernia, Julie Cavanagh-Kyros, Tamera Barrett, et al.
Journal of Leukocyte Biology
|
August 26, 2015
Dual role of ERK5 in the regulation of T cell receptor expression at the T cell surface
Xavier Rovira-Clavé, Maria Angulo-Ibáñez, Cathy Tournier, et al.
Molecular and Cellular Neurosciences
|
March 2, 2005
Activation of integrin alpha5beta1 delays apoptosis of Ntera2 neuronal cells
Rosemary M Gibson, Susan E Craig, Laura Heenan, et al.
Biomedicines
|
November 11, 2022
Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways
Serena Filiberti, Mariapia Russo, Silvia Lonardi, et al.
Cellular Signalling
|
July 30, 2010
Alternative ERK5 regulation by phosphorylation during the cell cycle
Francisco A Iñesta-Vaquera, David G Campbell, Cathy Tournier, et al.
FEBS Letters
|
February 7, 2006
The regulation of Bax by c-Jun N-terminal protein kinase (JNK) is a prerequisite to the mitochondrial-induced apoptotic pathway
Emmanouil S Papadakis, Katherine G Finegan, Xin Wang, et al.
European Journal of Immunology
|
September 16, 2008
ERK5 regulation in naïve T-cell activation and survival
Olga Ananieva, Andrew Macdonald, Xin Wang, et al.
Cancer Research
|
February 5, 2015
ERK5 is a critical mediator of inflammation-driven cancer
Katherine G Finegan, Diana Perez-Madrigal, James R Hitchin, et al.
Page
of 5